ACCESSION: MSBNK-SMB_Measured-HSA015P0244003
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 10
COMMENT: RAW_SPEC {'EL24_pos_10546': {'bp': 83328.0, 'sum': 371163.0}, 'Blanc1-pos_10841': {'bp': 73130.0, 'sum': 383474.0}, 'EL14_pos_10563': {'bp': 71706.0, 'sum': 344435.0}, 'EL13_pos_10564': {'bp': 64919.0, 'sum': 367881.0}, 'EL20_pos_10551': {'bp': 54170.0, 'sum': 238322.0}, 'EL09_pos_10559': {'bp': 53910.0, 'sum': 263937.0}, 'EL12_pos_10593': {'bp': 42948.0, 'sum': 292427.0}, 'EL19_pos_10636': {'bp': 36321.0, 'sum': 280382.0}, 'Blanc3-pos_10473': {'bp': 35065.0, 'sum': 209176.0}, 'EL22_pos_10666': {'bp': 34990.0, 'sum': 282888.0}}
COMMENT: RETENTION_TIME_STDEV 0.012
COMMENT: PRECURSOR_M/Z_RAW 244.190828
COMMENT: PRECURSOR_M/Z_STDEV 0.000083
COMMENT: PRECURSOR_IN_MS1 mz 244.190732; int 49.400; delta(ppm) 1.092519
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.049; C13H25NO3; [M+H]+; delta(ppm) 0.049345
COMMENT: PROPOSED_MF MS-FINDER 3.314; C13H25NO3; [M+H]+; delta(ppm) 0.048721
COMMENT: PROPOSED_MF SIRIUS5_Sirius 43.220; C13H25NO3; [M+H]+; delta(ppm) 0.048721
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C13H25NO3; [M+H]+; delta(ppm) 0.048721
COMMENT: PROPOSED_MF SIRIUS6_Sirius 53.728; C13H25NO3; [M+H]+; delta(ppm) 0.048721
COMMENT: PROPOSED_MF SIRIUS6_Sirius 30.135; C12H29NSi2; [M+H]+; delta(ppm) -207521.006793
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.374; C11H23N4O2; [M+H]+; delta(ppm) 5.547173
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C13H25NO3; [M+H]+; delta(ppm) 0.048721
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.909; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCC(=O)NCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.457; GSYSEQUYQXPNHH-WEUYFXHZNA-N; [M+H]+; CC(C)OC(=O)[C@H](O)[C@@H](N)CC1CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.383; WMCLKPGRHOQJAI-UHFFFAOYSA-N; [M+H]+; O=C(N(CCCO)C1CCOC(C)(C)C1)CC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.312; KWMRFDVSMVGRLI-UHFFFAOYSA-N; [M+H]+; OCC1(CNCC2CCCC2)CC(O)C(O)C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.179; PGJJWEQJZIWKQY-QWAQRTLVNA-N; [M+H]+; CCOC(=O)[C@@]1(CCCC[C@@]1(O)CC)N(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.923; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M+H]+; N-Undecanoylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.838; KWMRFDVSMVGRLI-UHFFFAOYSA-N; [M+H]+; 4-{[(cyclopentylmethyl)amino]methyl}-4-(hydroxymethyl)cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.807; PGJJWEQJZIWKQY-QWAQRTLVNA-N; [M+H]+; UNPD49763
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.798; BORDUPYPIRUXNW-NVHKGDCHNA-N; [M+H]+; UNPD186376
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.748; WMCLKPGRHOQJAI-UHFFFAOYSA-N; [M+H]+; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.731; GSYSEQUYQXPNHH-WEUYFXHZNA-N; [M+H]+; CYCLOHEXYL-NORSTATINE
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BORDUPYPIRUXNW-NVHKGDCHNA-N; [M+H]+; UNPD186376
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.993; WMCLKPGRHOQJAI-UHFFFAOYSA-N; [M+H]+; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.978; PGJJWEQJZIWKQY-QWAQRTLVNA-N; [M+H]+; UNPD49763
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.672; GSYSEQUYQXPNHH-WEUYFXHZNA-N; [M+H]+; CYCLOHEXYL-NORSTATINE
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.470; KWMRFDVSMVGRLI-UHFFFAOYSA-N; [M+H]+; 4-{[(cyclopentylmethyl)amino]methyl}-4-(hydroxymethyl)cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.319; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M+H]+; N-Undecanoylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.415; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M+H]+; 2-(undecanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.375; OXPWHPCCUXESFQ-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(3-hydroxypropyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.511; VCIBBCGSWUMTGW-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[[2-(hydroxymethyl)cyclohexyl]methyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; DBWREWKJBLECNR-MNOVXSKESA-N; [M+H]+; tert-butyl N-[[(1R,3S)-3-(hydroxymethyl)cyclohexyl]methyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.480; DIQOZPGKFVICKN-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(3-hydroxypropyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.432; NJXIJKXUFFXDMC-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(8-oxooctyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.400; HLSJFBQWCBNSQQ-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(2-hydroxyethyl)-2,2-dimethylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.330; ZLEBLWDLKHDYEW-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(1-cyclopentyl-3-hydroxypropan-2-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.264; YNBRORWNNGUYQA-NSHDSACASA-N; [M+H]+; tert-butyl N-[(1R)-1-cyclohexyl-2-hydroxyethyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.774; CSBKKQVPRRRVQQ-UHFFFAOYSA-N; [M+H]+; heptyl 2-(diethylamino)-2-oxoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.745; VXKVVXXJHGUYAQ-UHFFFAOYSA-N; [M+H]+; 6-[3-(2-ethoxyethoxy)propyl]-8-oxa-6-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.517; YXZJRETWUVFEFX-ZJUUUORDSA-N; [M+H]+; tert-butyl (2S,4R)-4-[(2-methylpropan-2-yl)oxy]pyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; ASVYJCJXBYNYKQ-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(5,5-dimethyl-1-oxohexan-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -139.754; HEUQYIQQCNOXOG; [M+H]+; acylglycine C:11
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.426; SZUMGHGZFKDFPU; [M+H]+; 3-methyl-2-(octanoylamino)butanoic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -220.950; GSYSEQUYQXPNHH; [M+H]+; propan-2-yl 3-amino-4-cyclohexyl-2-hydroxybutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.512; NJXIJKXUFFXDMC; [M+H]+; Carbamic acid, (8-oxooctyl)-, 1,1-dimethylethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.060; ZZAPENIYDFOWME; [M+H]+; Ethyl N-(2,3-dimethyl-2-isopropyl-1-oxobutyl)glycinate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -278.106; YNBRORWNNGUYQA; [M+H]+; N-Boc-D-cyclohexylglycinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -286.661; OXPWHPCCUXESFQ; [M+H]+; Boc-4-Piperidinepropanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -295.906; CSBKKQVPRRRVQQ; [M+H]+; Heptyl N,N-diethyloxamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.434; KWMRFDVSMVGRLI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -369.303; WMCLKPGRHOQJAI; [M+H]+; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -381.738; PGJJWEQJZIWKQY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -390.238; BORDUPYPIRUXNW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -397.405; JTKDORYHWJDUAS; [M+H]+; 1-(4,4-Diethoxybutyl)piperidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -398.372; VXKVVXXJHGUYAQ; [M+H]+; 6-[3-(2-ethoxyethoxy)propyl]-8-oxa-6-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.226; HEUQYIQQCNOXOG; [M+H]+; acylglycine C:11
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -231.742; SZUMGHGZFKDFPU; [M+H]+; N-Octanoyl-L-valine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -284.347; HEUQYIQQCNOXOG; [M+H]+; 2-undecanamidoacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -296.295; NJXIJKXUFFXDMC; [M+H]+; tert-Butyl 8-oxooctylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -335.021; ZLEBLWDLKHDYEW; [M+H]+; tert-butyl N-[(2R)-1-cyclopentyl-3-hydroxypropan-2-yl]carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -347.276; YNBRORWNNGUYQA; [M+H]+; N-Boc-D-cyclohexylglycinol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -397.816; DBWREWKJBLECNR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -420.419; OXPWHPCCUXESFQ; [M+H]+; Tert-butyl 4-(3-hydroxypropyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -424.067; VXKVVXXJHGUYAQ; [M+H]+; 6-(3-(2-Ethoxyethoxy)propyl)-8-oxa-6-azabicyclo(3.2.1)octane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -431.202; KWMRFDVSMVGRLI; [M+H]+; 4-{[(cyclopentylmethyl)amino]methyl}-4-(hydroxymethyl)cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -433.840; GSYSEQUYQXPNHH; [M+H]+; Cyclohexyl-norstatine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.592; SZUMGHGZFKDFPU; [M+H]+; N-Octanoyl-L-valine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C13H26N1O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 17.223
MS$FOCUSED_ION: PRECURSOR_M/Z 244.190732
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000x-9350000000-0c08db73992eb5f22562
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0545302 389.8889 55.055238 0.4178 124.13 0.6970 10 f{C4H7}/5.51ppm,p-C9H19N1O3
  57.0701545 209.0480 57.070871 0.7184 56.80 0.4909 10 f{C4H9}/4.87ppm,p-C9H17N1O3
  67.0543755 109.1088 67.055117 0.4772 40.93 0.5879 10 f{C5H7}/2.22ppm,p-C8H19N1O3
  69.0700220 275.8783 69.070765 0.4343 69.63 0.7212 10 f{C5H9}/2.10ppm,p-C8H17N1O3
  71.0856079 89.7727 71.086351 1.1254 25.82 0.3167 9 f{C5H11}/1.14ppm,p-C8H15N1O3
  79.0542165 68.5979 79.054949 1.2017 24.62 -0.0476 8 f{C6H7}/-0.13ppm,p-C7H19N1O3
  81.0699546 284.6893 81.070681 0.7524 88.48 0.8182 10 f{C6H9}/0.96ppm,p-C7H17N1O3
  83.0856056 337.8998 83.086325 0.5657 116.50 0.6364 10 f{C6H11}/0.95ppm,p-C7H15N1O3
  93.0698911 128.9890 93.070558 1.2786 57.40 0.1000 9 f{C7H9}/0.15ppm,p-C6H17N1O3
  95.0855716 168.9760 95.086224 0.6941 49.37 0.7333 10 f{C7H11}/0.47ppm,p-C6H15N1O3
  97.1012831 257.8844 97.101920 0.6694 81.01 0.3576 10 f{C7H13}/1.09ppm,p-C6H13N1O3
  107.0855087 140.4374 107.086051 0.9432 35.16 1.0000 10 f{C8H11}/-0.17ppm,p-C5H15N1O3
  163.1480716 349.6936 163.148409 0.9562 91.54 0.7576 10 f{C12H19}/-0.34ppm,p-C1H7N1O3
  181.1586707 306.4399 181.159061 1.2586 97.22 0.8061 10 f{C12H21O1}/-0.12ppm,p-C1H5N1O2
  242.2842750 999.0000 242.284636 0.4458 0.00 0.6364 10 ?
  243.1744445 163.3904 243.174806 0.9787 50.36 0.5476 8 ?
  243.2876021 287.7032 243.287964 1.0440 39.11 0.4182 10 ?
PK$NUM_PEAK: 17
PK$PEAK: m/z int. rel.int.
  55.054530 389.89 389
  57.070155 209.05 209
  67.054375 109.11 109
  69.070022 275.88 275
  71.085608 89.77 89
  79.054217 68.60 68
  81.069955 284.69 284
  83.085606 337.90 337
  93.069891 128.99 128
  95.085572 168.98 168
  97.101283 257.88 257
  107.085509 140.44 140
  163.148072 349.69 349
  181.158671 306.44 306
  242.284275 999.00 999
  243.174444 163.39 163
  243.287602 287.70 287
//
